Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

   40,287,245      
Direct Value   $128,455,406    

Indirect Value

   $40,265,984      
Total Shares   87,362,343      
Total Value   $168,721,391      


Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407 Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    99   
    96    

     Stock price went up :
    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-05 4 B $0.63 $9,953 D/D 15,798 3,159,999 2.37 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-05 4 B $0.61 $19,274 I/I 31,596 3,159,999 1.5 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-08 4 B $0.65 $65,001 I/I 100,002 3,210,000 1.5 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-08 4 B $0.65 $32,501 D/D 50,001 3,210,000 2.37 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-09 4 B $0.66 $23,799 D/D 36,059 3,246,059 2.37 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-09 4 B $0.66 $47,598 I/I 72,118 3,246,059 1.5 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-10 4 B $0.79 $43,954 I/I 55,638 3,273,878 1.5 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-10 4 B $0.79 $21,977 D/D 27,819 3,273,878 2.37 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-11 4 B $0.74 $63,730 D/D 86,122 3,360,000 2.45 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-05-11 4 B $0.74 $127,461 I/I 172,244 3,360,000 1.5 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-05-19 4 B $0.63 $30,522 I/I 48,448 3,384,224 2.25 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-05-19 4 B $0.63 $15,261 D/D 24,224 3,384,224 3.92 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-14 4 B $0.64 $112,497 D/D 175,776 15,500,000 2.45 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-14 4 B $0.64 $224,993 I/I 351,552 15,500,000 1.5 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-15 4 B $0.58 $75,980 I/I 131,000 15,565,500 1.5 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-15 4 B $0.58 $37,990 D/D 65,500 15,565,500 2.37 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-16 4 B $0.58 $89,088 I/I 153,600 15,642,300 1.5 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-16 4 B $0.58 $44,544 D/D 76,800 15,642,300 2.37 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-08-17 4 B $0.59 $30,490 I/I 52,004 15,668,302 2.25 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-08-17 4 B $0.59 $15,245 D/D 26,002 15,668,302 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-08-18 4 B $0.61 $19,307 D/D 31,698 15,700,000 3.92 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-08-18 4 B $0.61 $38,615 I/I 63,396 15,700,000 2.25 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-08-21 4 B $0.61 $19,069 I/I 31,128 15,715,564 2.17 -
AVTX Avalo Therapeutics, Inc Director   –       •       •   2017-08-21 4 B $0.61 $9,535 D/D 15,564 15,715,564 3.84 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2017-08-22 4 B $0.62 $11,895 D/D 19,301 15,734,865 2.37 -
  790  Records found
  1   2  3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32      
  Page 2 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us